title: Your patient has chronic leukemia: Now what?
abstract: Although still in their infancy, biologic therapies for hematologic cancers are making rapid strides, diminishing the role of chemotherapy and offering long-term remission. More patients are surviving cancer and therefore are increasingly being seen by primary care physicians, who must be aware of complications of standard and newer treatments and how to manage them.
authors: Chairman, Department of Hematology and Medical Oncology, and Staff, Transplantation Center and Department of Cancer Biology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA. E-mail: kalaycm@ccf.org.|Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
authors: Matt
authors: M
authors: Kalaycio
mesh_terms: D001691:Biological Therapy / Q000379:methods / Q000639:trends*; D000073116:Cancer Survivors; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D011320:Primary Health Care / Q000379:methods*; D016896:Treatment Outcome